Locations:
Search
Procedural success tops 99 percent with mortality of 0.1 percent
Findings carry implications for clinical development of Akt inhibitors
Median treatment time trimmed to 52 minutes
New complement to Grand Rounds proves an instant hit
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
An experienced center is key
Surgeon who did first U.S. post-approval implant shares his take
A new spin on collapse therapy overcomes devastating pneumonia
Analysis finds surprisingly high complications with transvenous devices
U.S. patients have less-typical characteristics, greater comorbidities
A new opportunity to improve response rates to CRT
Advertisement
Advertisement